(MRVL) Marvell Technology - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5738741041
Stock:
Total Rating 32
Risk 76
Buy Signal -0.32
| Risk 5d forecast | |
|---|---|
| Volatility | 51.2% |
| Relative Tail Risk | -5.74% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.16 |
| Alpha | -48.69 |
| Character TTM | |
|---|---|
| Beta | 2.449 |
| Beta Downside | 2.659 |
| Drawdowns 3y | |
|---|---|
| Max DD | 60.79% |
| CAGR/Max DD | 0.39 |
EPS (Earnings per Share)
Revenue
Description: MRVL Marvell Technology
Marvell Technology, Inc., together with its subsidiaries, provides data infrastructure semiconductor solutions, spanning the data center core to network edge. The company develops and scales system-on-a-chip architectures, integrating analog, mixed-signal, and digital signal processing functionality. It offers a portfolio of ethernet solutions, including spanning controllers, network adapters, physical transceivers, and switches; single or multiple core processors; and custom application specific integrated circuits. The company also provides interconnect products, including pulse amplitude modulation, coherent and coherent-lite digital signal processors (DSPs), laser drivers, trans-impedance amplifiers, silicon photonics, co-packaged optics, linear pluggable optics chipsets, data center interconnect, active electrical cable DSPs and peripheral component interconnect express retimer solutions; fibre channel products comprising host bus adapters and controllers; storage controllers for hard disk drives and solid-state-drives; host system interfaces, including serial advanced technology attachment and serial attached SCSI, peripheral component interconnect express, non-volatile memory express (NVMe), and NVMe over fabrics. It operates in the United States, Argentina, China, India, Israel, Japan, Singapore, South Korea, Taiwan, and Vietnam. Marvell Technology, Inc. was incorporated in 1995 and is headquartered in Wilmington, Delaware.
Piotroski VR‑10 (Strict, 0-10) 5.5
| Net Income: 2.47b TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.07 > 0.02 and ΔFCF/TA 0.15 > 1.0 |
| NWC/Revenue: 35.62% < 20% (prev 19.59%; Δ 16.03% < -1%) |
| CFO/TA 0.09 > 3% & CFO 1.89b > Net Income 2.47b |
| Net Debt (3.00b) to EBITDA (4.37b): 0.69 < 3 |
| Current Ratio: 2.01 > 1.5 & < 3 |
| Outstanding Shares: last quarter (869.9m) vs 12m ago 0.49% < -2% |
| Gross Margin: 50.69% > 18% (prev 0.40%; Δ 5029 % > 0.5%) |
| Asset Turnover: 37.74% > 50% (prev 27.27%; Δ 10.48% > 0%) |
| Interest Coverage Ratio: 14.82 > 6 (EBITDA TTM 4.37b / Interest Expense TTM 207.3m) |
Altman Z'' 2.14
| A: 0.13 (Total Current Assets 5.51b - Total Current Liabilities 2.74b) / Total Assets 21.58b |
| B: 0.05 (Retained Earnings 1.01b / Total Assets 21.58b) |
| C: 0.15 (EBIT TTM 3.07b / Avg Total Assets 20.65b) |
| D: 0.13 (Book Value of Equity 1.01b / Total Liabilities 7.52b) |
| Altman-Z'' Score: 2.14 = BBB |
Beneish M -2.90
| DSRI: 1.07 (Receivables 1.55b/997.9m, Revenue 7.79b/5.38b) |
| GMI: 0.78 (GM 50.69% / 39.60%) |
| AQI: 0.86 (AQ_t 0.69 / AQ_t-1 0.81) |
| SGI: 1.45 (Revenue 7.79b / 5.38b) |
| TATA: 0.03 (NI 2.47b - CFO 1.89b) / TA 21.58b) |
| Beneish M-Score: -2.90 (Cap -4..+1) = A |
What is the price of MRVL shares?
As of February 28, 2026, the stock is trading at USD 81.69 with a total of 19,955,095 shares traded.
Over the past week, the price has changed by +2.78%, over one month by -1.50%, over three months by -8.56% and over the past year by -6.49%.
Over the past week, the price has changed by +2.78%, over one month by -1.50%, over three months by -8.56% and over the past year by -6.49%.
Is MRVL a buy, sell or hold?
Marvell Technology has received a consensus analysts rating of 4.49.
Therefore, it is recommended to buy MRVL.
- StrongBuy: 23
- Buy: 9
- Hold: 5
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MRVL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 115.7 | 41.6% |
| Analysts Target Price | 115.7 | 41.6% |
MRVL Fundamental Data Overview February 28, 2026
P/E Trailing = 27.919
P/E Forward = 25.641
P/S = 8.6287
P/B = 5.5368
P/EG = 1.5245
Revenue TTM = 7.79b USD
EBIT TTM = 3.07b USD
EBITDA TTM = 4.37b USD
Long Term Debt = 3.97b USD (from longTermDebt, last quarter)
Short Term Debt = 631.0m USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.00b USD (from netDebt column, last quarter)
Enterprise Value = 69.56b USD (67.25b + Debt 5.03b - CCE 2.71b)
Interest Coverage Ratio = 14.82 (Ebit TTM 3.07b / Interest Expense TTM 207.3m)
EV/FCF = 44.08x (Enterprise Value 69.56b / FCF TTM 1.58b)
FCF Yield = 2.27% (FCF TTM 1.58b / Enterprise Value 69.56b)
FCF Margin = 20.25% (FCF TTM 1.58b / Revenue TTM 7.79b)
Net Margin = 31.75% (Net Income TTM 2.47b / Revenue TTM 7.79b)
Gross Margin = 50.69% ((Revenue TTM 7.79b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 51.57% (prev 50.38%)
Tobins Q-Ratio = 3.22 (Enterprise Value 69.56b / Total Assets 21.58b)
Interest Expense / Debt = 1.02% (Interest Expense 51.2m / Debt 5.03b)
Taxrate = 14.18% (314.1m / 2.22b)
NOPAT = 2.64b (EBIT 3.07b * (1 - 14.18%))
Current Ratio = 2.01 (Total Current Assets 5.51b / Total Current Liabilities 2.74b)
Debt / Equity = 0.36 (Debt 5.03b / totalStockholderEquity, last quarter 14.06b)
Debt / EBITDA = 0.69 (Net Debt 3.00b / EBITDA 4.37b)
Debt / FCF = 1.90 (Net Debt 3.00b / FCF TTM 1.58b)
Total Stockholder Equity = 13.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.98% (Net Income 2.47b / Total Assets 21.58b)
RoE = 18.25% (Net Income TTM 2.47b / Total Stockholder Equity 13.55b)
RoCE = 17.53% (EBIT 3.07b / Capital Employed (Equity 13.55b + L.T.Debt 3.97b))
RoIC = 14.76% (NOPAT 2.64b / Invested Capital 17.86b)
WACC = 13.96% (E(67.25b)/V(72.28b) * Re(14.94%) + D(5.03b)/V(72.28b) * Rd(1.02%) * (1-Tc(0.14)))
Discount Rate = 14.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.42%
[DCF] Terminal Value 62.08% ; FCFF base≈1.51b ; Y1≈1.72b ; Y5≈2.35b
[DCF] Fair Price = 18.05 (EV 18.30b - Net Debt 3.00b = Equity 15.30b / Shares 847.3m; r=13.96% [WACC]; 5y FCF grow 15.90% → 2.90% )
EPS Correlation: -5.76 | EPS CAGR: -48.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.11 | Revenue CAGR: 12.29% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.75 | Chg7d=-0.006 | Chg30d=-0.032 | Revisions Net=-15 | Analysts=28
EPS next Year (2027-01-31): EPS=3.38 | Chg7d=-0.024 | Chg30d=-0.181 | Revisions Net=-15 | Growth EPS=+19.5% | Growth Revenue=+21.9%
[Analyst] Revisions Ratio: -0.88 (1 Up / 16 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.4% (Discount Rate 14.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +8.8% (Analyst 20.2% - Implied 11.4%)
P/E Forward = 25.641
P/S = 8.6287
P/B = 5.5368
P/EG = 1.5245
Revenue TTM = 7.79b USD
EBIT TTM = 3.07b USD
EBITDA TTM = 4.37b USD
Long Term Debt = 3.97b USD (from longTermDebt, last quarter)
Short Term Debt = 631.0m USD (from shortTermDebt, last quarter)
Debt = 5.03b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 3.00b USD (from netDebt column, last quarter)
Enterprise Value = 69.56b USD (67.25b + Debt 5.03b - CCE 2.71b)
Interest Coverage Ratio = 14.82 (Ebit TTM 3.07b / Interest Expense TTM 207.3m)
EV/FCF = 44.08x (Enterprise Value 69.56b / FCF TTM 1.58b)
FCF Yield = 2.27% (FCF TTM 1.58b / Enterprise Value 69.56b)
FCF Margin = 20.25% (FCF TTM 1.58b / Revenue TTM 7.79b)
Net Margin = 31.75% (Net Income TTM 2.47b / Revenue TTM 7.79b)
Gross Margin = 50.69% ((Revenue TTM 7.79b - Cost of Revenue TTM 3.84b) / Revenue TTM)
Gross Margin QoQ = 51.57% (prev 50.38%)
Tobins Q-Ratio = 3.22 (Enterprise Value 69.56b / Total Assets 21.58b)
Interest Expense / Debt = 1.02% (Interest Expense 51.2m / Debt 5.03b)
Taxrate = 14.18% (314.1m / 2.22b)
NOPAT = 2.64b (EBIT 3.07b * (1 - 14.18%))
Current Ratio = 2.01 (Total Current Assets 5.51b / Total Current Liabilities 2.74b)
Debt / Equity = 0.36 (Debt 5.03b / totalStockholderEquity, last quarter 14.06b)
Debt / EBITDA = 0.69 (Net Debt 3.00b / EBITDA 4.37b)
Debt / FCF = 1.90 (Net Debt 3.00b / FCF TTM 1.58b)
Total Stockholder Equity = 13.55b (last 4 quarters mean from totalStockholderEquity)
RoA = 11.98% (Net Income 2.47b / Total Assets 21.58b)
RoE = 18.25% (Net Income TTM 2.47b / Total Stockholder Equity 13.55b)
RoCE = 17.53% (EBIT 3.07b / Capital Employed (Equity 13.55b + L.T.Debt 3.97b))
RoIC = 14.76% (NOPAT 2.64b / Invested Capital 17.86b)
WACC = 13.96% (E(67.25b)/V(72.28b) * Re(14.94%) + D(5.03b)/V(72.28b) * Rd(1.02%) * (1-Tc(0.14)))
Discount Rate = 14.94% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.42%
[DCF] Terminal Value 62.08% ; FCFF base≈1.51b ; Y1≈1.72b ; Y5≈2.35b
[DCF] Fair Price = 18.05 (EV 18.30b - Net Debt 3.00b = Equity 15.30b / Shares 847.3m; r=13.96% [WACC]; 5y FCF grow 15.90% → 2.90% )
EPS Correlation: -5.76 | EPS CAGR: -48.79% | SUE: -4.0 | # QB: 0
Revenue Correlation: 60.11 | Revenue CAGR: 12.29% | SUE: 0.42 | # QB: 0
EPS next Quarter (2026-04-30): EPS=0.75 | Chg7d=-0.006 | Chg30d=-0.032 | Revisions Net=-15 | Analysts=28
EPS next Year (2027-01-31): EPS=3.38 | Chg7d=-0.024 | Chg30d=-0.181 | Revisions Net=-15 | Growth EPS=+19.5% | Growth Revenue=+21.9%
[Analyst] Revisions Ratio: -0.88 (1 Up / 16 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 11.4% (Discount Rate 14.9% - Earnings Yield 3.6%)
[Growth] Growth Spread = +8.8% (Analyst 20.2% - Implied 11.4%)